Cargando…
Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial
BACKGROUND: GHB (gamma-hydroxybutyrate) and its pro-drugs GBL (gamma-butyrolactone) and 1,4-butanediol (1,4-BD) are central nervous system depressants whose street names include ‘G’ and ‘liquid ecstasy’. They are used recreationally predominately for their stimulant and pro-sexual effects or for sed...
Autores principales: | Lingford-Hughes, Anne, Patel, Yash, Bowden-Jones, Owen, Crawford, Mike J., Dargan, Paul I., Gordon, Fabiana, Parrott, Steve, Weaver, Tim, Wood, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039898/ https://www.ncbi.nlm.nih.gov/pubmed/27677382 http://dx.doi.org/10.1186/s13063-016-1593-9 |
Ejemplares similares
-
Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability
por: Floyd, Christopher N., et al.
Publicado: (2017) -
Characterization of the GHB Withdrawal Syndrome
por: Wolf, Casper J. H., et al.
Publicado: (2021) -
Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study
por: Kamal, Rama M, et al.
Publicado: (2015) -
Baclofen versus lorazepam for alcohol withdrawal
por: Garag, Sagar S., et al.
Publicado: (2019) -
Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial
por: Beurmanjer, Harmen, et al.
Publicado: (2018)